Introduction
============

Pain is a common symptom of any illness, and is defined by the International Association for the Study of Pain as "an unpleasant sensory and emotional experience associated with either actual or potential tissue damage, or described in terms of such damage."[@b1-jpr-5-503],[@b2-jpr-5-503] The alerting function of pain evokes protective responses and is intended to keep tissue damage to a minimum.[@b3-jpr-5-503] Postoperative pain is an expected and inevitable symptom in a surgical patient associated with surgical tissue damage, the presence of drains and tubes, postoperative complications, or a combination of the above mentioned.[@b2-jpr-5-503],[@b4-jpr-5-503],[@b5-jpr-5-503] The physiological consequences comprise the activation of the "stress response,"[@b2-jpr-5-503] evoking respiratory, cardiovascular, thromboembolic, gastrointestinal, musculoskeletal, and psychological complications.[@b2-jpr-5-503],[@b6-jpr-5-503]--[@b12-jpr-5-503] To ease recovery, functional ability, and to reduce postoperative morbidity, pain should be treated as adequately as possible. Careful monitoring by the surgeon or anesthesiologist can result in more effective control of postoperative pain.[@b13-jpr-5-503] Pain is a subjective sensation that can be described according to several relevant features or attributes such as quality, location, intensity, aversiveness, emotional impact, and frequency.[@b13-jpr-5-503] Among these attributes, intensity is recognized as one of the relevant clinical dimensions of the pain experience.[@b14-jpr-5-503] Various rating scales have been described to measure pain intensity that are partially subjective, with difficulties in administration to patients with special needs.[@b15-jpr-5-503] Such scales include the visual analog scale (VAS), numerical rating scale (NRS), and verbal rating scale (VRS).

The pain point system scale (PPSS) was introduced to overcome the drawbacks involved in postoperative pain intensity assessment and when objective pain assessment is desired for study purposes but there is no available data (due to lack of communication with patient or patient's inability to recall). The PPSS inputs the type of analgesics administered and scores each given dose separately. The total postoperative pain score or the score of each pain episode can be used for evaluation. The scoring system is based on the analgesic ladder proposed by the World Health Organization as a step approach to pain management.[@b16-jpr-5-503] It classifies analgesics into three groups. The first group comprises nonnarcotic weak analgesics (paracetamol/acetaminophen), the second group comprises nonnarcotic nonsteroidal antiinflammatory drugs and weak narcotics (codeine), and the third group comprises strong narcotic analgesics ([Table 1](#t1-jpr-5-503){ref-type="table"}). Specifically, one dose of paracetamol 600 mg equals 1 point; a dose of paracetamol 500 mg plus 10 mg codeine equals 3 points; each dose of a nonsteroidal antiinflammatory drug (diclofenac 75 mg, parecoxib 40 mg, or lornoxicam 8 mg) equals 3 points; and each dose of an opioid (tramadol 50 mg or dextropropoxyphene hydrochloride 75 mg or pethidine hydrochloride 50 mg) equals 7 points.

This study was designed to detect the correlation between the PPSS and the commonly used pain scales (VAS, NRS, and VRS), and to determine its validity for use in retrospective studies.

Patients and methods
====================

This prospective cross-sectional study was performed on postoperative patients admitted to the Urology Department of Hippokration General Hospital (Thessaloniki, Greece) for a scheduled operation from March to October 2011.The patients underwent a variety of procedures ([Table 2](#t2-jpr-5-503){ref-type="table"}). This research was approved by the local ethics committee according to the principles of the Declaration of Helsinki on ethical principles of medical research.

Participants
------------

Patients were randomly selected and recruited. Preoperative exclusion criteria were the inability to read or speak Greek, impaired cognitive function, performance status of at least two according to the Zubrod scale,[@b17-jpr-5-503] emergency procedures, chronic administration of analgesics, and chronic opioid or substance abuse. Postoperatively, all patients with continuous epidural or intravenous analgesia or a drop in hemoglobin level to \<7 g/dL, patients who were temporally or spatially disoriented or unable to recognize familiar persons, as well as those with pain episodes that were encountered without medications (eg, bladder flushing or fixing catheter's balloon), were excluded. To eliminate recall bias, patients were allocated into three groups according to the method of anesthetic administration (ie, local infiltration, spinal, or general anesthesia).

Measures
--------

### VAS

The VAS is presented as a 10 cm horizontal line, anchored by verbal descriptors labeled with "no pain" at point zero (0 cm) and "worst imaginable pain" at point ten (10 cm). The patient marks the line at the point corresponding to the intensity of the pain currently experienced. Using a 1 cm-per-point scale to measure the patient's score, the VAS provides ten levels of pain intensity.[@b18-jpr-5-503] Although line orientation is important, the horizontal VAS was chosen for the current study, as the reading and writing tradition for Greek people is horizontal, from left to right.[@b18-jpr-5-503],[@b19-jpr-5-503]

### NRS

The NRS is an applied pain scale describing zero as "no pain" and ten as "worst imaginable pain." The NRS is a horizontal line marked with numbers from zero to ten. The patient is asked to circle the currently experienced intensity of pain.

### VRS

VRS comprises a list of adjectives used to denote increasing pain intensities. The most common words used are no pain, mild pain, moderate pain, and severe/excruciating pain. For ease of recording, these adjectives are assigned numbers.[@b18-jpr-5-503]

### PPSS

PPSS is the proposed scale system for the assessment of postoperative pain in retrospective studies. The score is obtained as a summation of points for each analgesic administered (via the intravenous route in the current study). The proposed scale is to be used in a clearly comparative manner, comparing pain intensity scores in retrospective studies to extract conclusions regarding factors affecting pain. It does not offer specific correlation of a score with a given level of pain.

A wide-edge writing pen, 3 mm thick, was provided to accommodate writing difficulties and any sensory impairment related to anesthetic recovery (minimizing patients' effort to be precise). Each questionnaire was given on a separate A4 size paper with Times New Roman, size 20 font. Nonetheless, the VAS line was always exactly 10 cm long. The scales were completed in the presence of the research assistant, who gave all necessary instructions. The scale was removed from the patient's view after rating their pain intensity to exclude memory recall from the patient before the next scale was presented. The exact technique described by Gagliese et al was followed.[@b20-jpr-5-503]

Postoperative pain management
-----------------------------

An artificial neural network was developed for drug administration decision-making purposes in the current study, according to the perioperative care guidelines of the authors' hospital ([Figure 1](#f1-jpr-5-503){ref-type="fig"}).[@b21-jpr-5-503] The artificial neural network was developed in MATLAB R2009b (The MathWorks, Inc, Natick, MA).

The output was divided in two groups of nodes. Output A represented the three basic categories of analgesics: weak nonnarcotic analgesics, strong nonnarcotic nonsteroidal antiinflammatory drugs or weak narcotics, and strong narcotics. Output B represented the final decision.

Procedure
---------

At the time of admission, prior to the informed consent, the recruited patients were informed and each pain scale was completely described. During the first postoperative day, each pain episode was registered. The research assistant read the instructions to each patient. They were asked if the nature of the task was understood. If not, the instructions were repeated. The responses on the three scales and any additional comments were recorded. The patient's mental status was assessed prior to obtaining their response. Analgesic drugs were administered intravenously and were noted in a specific study record. Thirty minutes after analgesic administration, the same patient was asked to fill in the same pain scales to evaluate the analgesic effect. Full blood count was taken immediately after returning to the surgical ward.

Statistical analysis
--------------------

Data were analyzed by SPSS^®^ version 16 (SPSS Inc, Chicago, IL). Descriptive statistics were used to analyze the study sample and the patients' ability to complete the different pain scales.

### Evaluation sample sufficiency

To determine if the subscales were suitable for factor analysis, two statistical tests were used: (1) Bartlett's test of sphericity, which examines the interdependency of the subscales, and (2) the Kaiser--Meyer--Olkin criterion, which measures the sampling adequacy.[@b22-jpr-5-503] The Kaiser--Meyer--Olkin measure of sampling adequacy was 0.854 (patterns of correlations were relatively compact so factor analysis yielded distinct and reliable factors). Bartlett's test of sphericity led to an approximate chi-square distribution of 1080.626 with 15,000 degrees of freedom and very significant correlation (*P* = 0.000).

### Evaluation of the most efficient pain scale in the sample

In order to acquire methodologically sound and trustworthy data, each episode of pain was assessed by the three pain scales. Assuming that each patient felt the same pain intensity during the completion of each pain scale before and after analgesic administration, the following formula was used for each scale to test the efficacy of the treatment and monitor the progress:[@b23-jpr-5-503]
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### Evaluation of the most appropriate scoring system for PPSS

The main method of extracting factors and validity assessment was examined using a principal component exploratory factor analysis with varimax rotation. Using orthogonal (varimax) rotation, the variance between variable loads is maximized on a specific factor. This way, small loads become smaller and big loads become bigger with reduction of in-between values, making it easier to interpret the results.[@b24-jpr-5-503] The criterion of an eigenvalue of one or more (Kaiser rule) defined the number of the factors that were kept.[@b25-jpr-5-503] Cronbach's α was used to assess the internal consistency of the PPSS scoring system.[@b26-jpr-5-503] Cronbach's α is the most important index since it factors in the mean correlations of all variables and does not depend on their arrangement.[@b27-jpr-5-503]

### Correlation of PPSS to the most efficient pain scale

Inferential statistics were used for the correlation of pain scales to PPSS and other variables of the study. Pearson's and Spearman's rho correlation coefficients were used to correlate the most appropriate scoring system for PPSS to the most efficient pain scale.

Results
=======

In total, 150 patients were recruited. Twenty-six patients were excluded (six with postoperative confusion status and 20 with a pre/postoperative hemoglobin difference \>7 g/dL). A total of 262 postoperative pain episodes during the first postoperative day were analyzed. The mean age of the study sample was 60.8 years (standard deviation 15.41 years; range 18--86 years). The ratio of male to female patients was 3.8:1 (98 males, 26 females). The demographic and baseline characteristics of each group are shown in [Table 2](#t2-jpr-5-503){ref-type="table"}.

The Kaiser--Meyer--Olkin index, which compares the size of the observed correlation coefficients to the size of the partial correlation coefficients for the sum of the analysis variables, was 85.4% (ie, reliable because it is \>80%). In addition, the sphericity test (Bartlett's sign \< 0.01) was rejected on a level of statistical significance (*P* \< 0.001) for an approximate Chi-square distribution of 1080.626. Consequently, the coefficients were not all zero and the second acceptance of factor analysis was satisfactory.

There were 1.92, 1.98, and 2.43 pain episodes during the first postoperative day per patient for the first, second, and third group, respectively. All patients were able to complete the three scales correctly. Patients of the first group did not require any help in completing the pain rating scales either before or after drug administration. In the second and third groups, 18.6% (n = 13) and 47.6% (n = 20) required further explanation on VAS and 8.6% (n = 6) and 38.1% (n = 16) required further explanation on both VAS and NRS, respectively. There was no significant correlation between education level and the inability to complete the scales. Postoperatively, the values for the second group and third group were 10% (n = 7) and 30.9% (n = 13) on VAS and 5.7% (n = 4) and 28.6% (n = 12) on both VAS and NRS, respectively. None of the patients had difficulty in the VRS scoring.

Using [Equation 1](#FD1){ref-type="disp-formula"}, pain intensity reduction was more accurate with VAS and NRS (mean 78.03% and 68.67%, respectively) than with VRS (mean 63.07%) ([Table 3](#t3-jpr-5-503){ref-type="table"}). Eight different scoring combinations (factors) for PPSS were tested. The appropriate factors are represented graphically as a Cattell scree plot in [Figure 2](#f2-jpr-5-503){ref-type="fig"}. It shows a distinct break at the fourth component and thereafter forms the linear part of the eigenvalue curve. Taking under consideration the eigenvalues greater than one, four factors satisfactorily interpret the data: component one 1--3--7; component two 10--30--70; component three 1--2--3; and component four 0--1--2 scores for each analgesic category, respectively. The reliability coefficient, Cronbach's α, was statistically significant and equal to 73.45%, 70.38%, 63.91%, 62.15% for the first, second, third, and fourth components, respectively. Therefore, the first component is the ideal scoring system for the PPSS.

The total number of episodes (n = 262) was used to correlate the 1--3--7 scoring system for PPSS to VAS. Pearson's and Spearman's rho correlation coefficients were applied. Multiple regression analysis of the remaining variables such as sex, age, body mass index, educational level, duration of operation, difference in hemoglobin, and NRS were evaluated ([Table 4](#t4-jpr-5-503){ref-type="table"}). A strong correlation of VAS to PPSS (rho = 0.715; *P* \< 0.001) and NRS (rho = 0.884; *P* \< 0.001) was found. The results were verified by Pearson's correlation (0.631 and 0.851, respectively; *P* \< 0.001). Less effect was found for prolonged operation times and higher blood loss, while inconsiderable effect was found for body mass index, age, and education level. [Figure 3](#f3-jpr-5-503){ref-type="fig"} shows the plotted linear regression between VAS and PPSS (r^2^ = 0.702).

The intergroup variability was also notable, since PPSS was found to correlate well with VAS in the first group (Pearson's = 0.847; *P* \< 0.001 and rho = 0.828; *P* \< 0.001) but less so in the other two groups. It is noteworthy that this decline in PPSS efficiency is accompanied by the proportional decline of NRS (Pearson's = 0.628 versus 0.620 for NRS and 0.702 versus 0.502 for PPSS in the second and third group, respectively) ([Table 5](#t5-jpr-5-503){ref-type="table"}).

Discussion
==========

This study examined the relationship between different pain scales in postoperative patients to construct the validity of PPSS. This proposed tool is intended for use in the pain intensity assessment of the postoperative period in retrospective studies. Three types of unidimensional pain measurement scales were considered: VAS, NRS, and VRS. All these tools are commonly used to measure pain intensity and are validated in both acute and chronic pain settings.[@b13-jpr-5-503],[@b28-jpr-5-503]

In the medical literature, several studies have evaluated the accuracy of each method and some have compared their results.[@b29-jpr-5-503] For example, de Boer et al showed that VAS is a sufficient tool for use in acute pain settings.[@b30-jpr-5-503] Failure rates of VAS are between 4%--11%, which are reduced if the tool is carefully explained to the patient.[@b31-jpr-5-503],[@b32-jpr-5-503] Kremer et al reported lower failure rates of 1%--2% in NRS and VRS, as they found a significant age difference between patients able to complete VAS and those who were not (mean age 75.3 versus 54.4 years; *P* \< 0.01).[@b23-jpr-5-503],[@b31-jpr-5-503] Failure rates are enhanced when dealing with children, patients with cognitive dysfunction, or when language difficulties exist.[@b32-jpr-5-503],[@b33-jpr-5-503]

In the current study, the efficiency of these tools was calculated to find the scale to compare to the PPSS. The efficacy of VAS was 78.03%. The proposed PPSS was examined against VAS and it was found to be correlated strongly and linearly, but less so than NRS to VAS. Both scales seem to weaken their correlation to VAS in patients who underwent longer operations and had higher blood loss. These groups (second and third) of patients underwent spinal or general anesthesia, and this could be a masked bias to the analysis.

PPSS is correlated to the duration of operation and blood loss, indicating the need for analgesics in the early postoperative period. It does not correlate at all to sex, age, body mass index, and education level, indicating the true relationship to the contributing factors.

The main drawbacks of this study were the short cohort, the age distribution (59--71 years), the male to female ratio (3.8:1), and the evaluation of only urologic patients. Additionally, patients under continuous or balanced anesthesia were excluded. More studies are required to assess the affinity of PPSS for the objective evaluation of postoperative pain and also to examine the possible deployment of this tool in cancer-related pain or in other patients with chronic pain.

Conclusion
==========

Pain rating scales have a fundamental place in clinical practice. The evidence suggests that patients are able to use them to communicate their pain experience and their response to treatment. Nevertheless, pain-measuring tools cannot be used retrospectively, especially when study purposes require pain assessment. The authors believe that PPSS will be a valuable tool in defining better treatment options and comparing therapies and patient preferences.

**Disclosure**

The authors report no conflicts of interest in this work.

![The artificial neural network schema shows the factors affecting the decision for specific drug administration.\
**Notes:** The first column shows all the factors (predictive covariates) that influence drug administration (input nodes). Output A nodes represent the three major analgesic categories according to the World Health Organization's "analgesic ladder." Output B represents the final decision (developed using MATLAB R2009B; The MathWorks, Inc, Natick, MA).\
**Abbreviations:** NRS, numerical rating scale; VAS, visual analog scale; VRS, visual rating scale.](jpr-5-503f1){#f1-jpr-5-503}

![Cattell scree plot for factor determination and evaluation of the proper scoring system.](jpr-5-503f2){#f2-jpr-5-503}

![The relationship between the visual analog scale and the proposed pain point system scale, showing linear and strong correlation.](jpr-5-503f3){#f3-jpr-5-503}

###### 

Scoring algorithm of pain point system scale based on administered drugs in the early postoperative period

  Drug                                      PPSS score (points/dose)
  ----------------------------------------- --------------------------
  Paracetamol (acetaminophen) 600 mg        1
  Paracetamol 500 mg + codeine 10 mg        3
  NSAIDs                                    3
   Diclofenac 75 mg                         
   Parecoxib 40 mg                          
   Lornoxicam 8 mg                          
  Opioids                                   7
   Tramadol 50 mg                           
   Dextropropoxyphene hydrochloride 75 mg   
   Pethidine hydrochloride 50 mg            

**Abbreviations:** NSAIDs, nonsteroidal antiinflammatory drugs; PPSS, pain point system scale.

###### 

Demographic and baseline characteristics of the patient groups

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                             First group: local infiltration anesthesia   Second group: spinal anesthesia   Third group: general anesthesia
  -------------------------------------------------------------------------- -------------------------------------------- --------------------------------- ----------------------------------------------
  Patient data                                                                                                                                              

   Number                                                                    12                                           70                                42

   Sex                                                                                                                                                      

    Male                                                                     12                                           52                                34

    Female                                                                   0                                            18                                8

  Age (years)                                                                                                                                               

   Mean ± SD                                                                 59.25 ± 5.3                                  65.0 ± 12.1                       54.89 ± 17.9

   Median (range)                                                            54 (22--84)                                  66 (19--86)                       56 (18--81)

  BMI (kg/m^2^)                                                                                                                                             

   Mean ± SD                                                                 27.58 ± 3.8                                  26.18 ± 3.7                       25.17 ± 3.8

  Education level, n (%)                                                                                                                                    

   Elementary school                                                         5 (41.66)                                    36 (51.43)                        12 (28.57)

   High school                                                               5 (41.66)                                    25 (35.71)                        23 (54.76)

   University                                                                2 (16.66)                                    9 (12.86)                         7 (16.66)

  Perioperative data                                                                                                                                        

   Operation (n)                                                             Circumcision (7)                             TUR-P (24)                        Varicocelectomy (13)

                                                                             Hydrocelectomy (5)                           TUR-BT (16)                       Radical prostatectomy (13)

                                                                                                                          URS (16)                          Radical nephrectomy (12)

                                                                                                                          Open prostatectomy (10)\          Radical cystectomy and bricker diversion (4)
                                                                                                                          MUS (4)                           

    Mean operation time ± SD (minutes)                                       32.58 ± 7.3                                  44.37 ± 19.9                      116.63 ± 62.4

    Range (minutes)                                                          19--43                                       11--110                           26--290

  Estimation of blood loss (g/dL)[a](#tfn3-jpr-5-503){ref-type="table-fn"}                                                                                  

   Mean ± SD                                                                 0.93 ± 0.65                                  2.75 ± 1.4                        2.8 ± 1.85

   Range                                                                     0.2--2.5                                     0.1--6.7                          0.2--6.9
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Note:**

Difference in hemoglobin level pre- and postoperatively.

**Abbreviations:** BMI, body mass index; MUS, midurethral sling; SD, standard deviation; TUR-BT, transurethral excision of bladder tumor; TUR-P, transurethral prostatectomy; URS, ureteroscopic lithotripsy.

###### 

Comparison of the treatment efficacy after intravenous administration of analgesics across the three pain scales

                                         First group: local infiltration anesthesia   Second group: spinal anesthesia   Third group: general anesthesia
  -------------------------------------- -------------------------------------------- --------------------------------- ---------------------------------
  Total pain episodes                    22                                           138                               102
  Pain episodes per patient              1.92                                         1.98                              2.43
  **Visual analog scale**                                                                                               
  Mean pretreatment value per patient    138.34                                       126.57                            208.07
  Mean posttreatment value per patient   24.9                                         36.2                              40.2
  Treatment efficacy                     82.0%                                        71.4%                             80.7%
                                         **Mean treatment efficacy value 78.03%**                                       
  **Numerical rating scale**                                                                                            
  Mean pretreatment value per patient    11.36                                        12.75                             20.38
  Mean posttreatment value per patient   1.77                                         6.29                              5.92
  Treatment efficacy                     84.4%                                        50.7%                             70.9%
                                         **Mean treatment efficacy value 68.67%**                                       
  **Verbal rating scale**                                                                                               
  Mean pretreatment value per patient    3.67                                         3.78                              5.98
  Mean posttreatment value per patient   0.98                                         1.54                              2.59
  Treatment efficacy                     73.3%                                        59.3%                             56.6%
                                         **Mean treatment efficacy value 63.07%**                                       

###### 

Multiple regression analysis for sex, age, body mass index, educational level, operation duration, and reduction in hemoglobin level

  VAS         NRS                                                 PPSS                                                Sex     Age     BMI                                                 Education level   Operation duration                                  Hemoglobin reduction
  ----------- --------------------------------------------------- --------------------------------------------------- ------- ------- --------------------------------------------------- ----------------- --------------------------------------------------- ---------------------------------------------------
  1           0.851[\*\*](#tfn6-jpr-5-503){ref-type="table-fn"}   0.631[\*\*](#tfn6-jpr-5-503){ref-type="table-fn"}   0.005   0.051   0.221[\*\*](#tfn6-jpr-5-503){ref-type="table-fn"}   0.052             0.398[\*\*](#tfn6-jpr-5-503){ref-type="table-fn"}   0.342[\*\*](#tfn6-jpr-5-503){ref-type="table-fn"}
  *P*-value   0.000                                               0.000                                               0.937   0.415   0.000                                               0.403             0.000                                               0.000

**Notes:**

No significance; VAS pain scale used as the independent variable.

**Abbreviations:** BMI, body mass index; NRS, numerical rating scale; PPSS, pain point system scale; VAS, visual analog scale.

###### 

Pearson's and Spearman's rho correlations in the three studied groups

                                          First group: local infiltration anesthesia   Second group: spinal anesthesia   Third group: general anesthesia                                           
  --------------------------------------- -------------------------------------------- --------------------------------- --------------------------------- ------- ------- ------- ------- ------- -------
  **Pearson's correlation to VAS**        1.000                                        0.971                             0.847                             1.000   0.628   0.620   1.000   0.702   0.502
  Significance (2-tailed)                 --                                           0.001                             0.001                             --      0.001   0.001   --      0.001   0.001
  n                                       22                                           22                                22                                138     138     138     102     102     102
  **Spearman's rho correlation to VAS**   1.000                                        0.960                             0.828                             1.000   0.564   0.602   1.000   0.792   0.634
  Significance (2-tailed)                 --                                           0.001                             0.001                             --      0.001   0.001   --      0.001   0.001
  n                                       22                                           22                                22                                138     138     138     102     102     102

**Abbreviations:** NRS, numerical rating scale; PPSS, pain point system scale; VAS, visual analog scale.
